WINSTON-SALEM, N.C. — Researchers at Wake Forest University Baptist Medical Center (WFUBMC) have discovered what may become a new weapon in the fight against breast cancer. For the first time, a peptide found in blood and tissue has been shown to i…
Richmond, Va. (Dec. 15, 2010) — Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown …
Investigators have demonstrated for the first time that the most common malignant childhood brain tumor, medulloblastoma, is actually several different diseases, each arising from distinct cells destined to become different structures. The breakthro…
A new process for creating a personalized vaccine may become a crucial tool in helping patients with colorectal cancer develop an immune response against their own tumors. This dendritic cell (DC) vaccine, developed at Dartmouth and described in a r…
HOUSTON – A vaccine that turns the immune system against brain tumor cells bearing a genetic mutation that drives the most aggressive form of glioblastoma multiforme improved survival of patients in a phase II clinical trial, researchers at Duke…
In patients with metastatic breast cancer, immune cells from a genetically matched donor can attack and shrink tumors, researchers from the National Cancer Institute (NCI) announced today at the Annual Meeting of the American Society of Clinical Oncology in Chicago. This is the first time researchers have clearly demonstrated this type of immune response, known as a graft-versus-tumor effect, acting against breast cancer.
Of all the neoplastic cells in human breast cancers, only a small minority – perhaps as few as one in 100 – appear to be capable of forming new malignant tumors, according to just-published research by scientists in the University of Michigan Comprehensive Cancer Center. The discovery could help researchers zero in on the most dangerous cancer cells to develop new, more effective treatments.
Listeria and certain strains of E. coli are the scourge of picnics, but researchers at Harvard Medical School and London’s Hammersmith Hospital show in the November Gene Therapy that combining bacterial components of these bad bugs can create a powerful vector against melanoma challenged mice.
Science Blog reported earlier this week on a study suggesting a connection between use of an early cell phone standard and brain tumors. A separate study announced today says that no link has been found between radio emissions from mobile phones and the growth of tumors in mice. The Australian study contradicts yet another, earlier investigation that did find a connection. No word on what sort of calling plan the recent mice were allowed in the three year experiment.